Berman Capital Advisors’s Sana Biotechnology SANA Stock Holding History

Berman Capital Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2K	Buy	+89	New	+$1.87K	﹤0.01%	1736

Other funds holding SANA

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berman Capital Advisors's SANA Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Sana Biotechnology (SANA) in Q3 2021: 89 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1736 among its holdings.

88 funds tracked by Wall St. Rank hold SANA as of Q3 2021.

Berman Capital Advisors held 89 shares of Sana Biotechnology worth $2K as of Q3 2021.
Sana Biotechnology was a new Berman Capital Advisors position in Q3 2021.
Sana Biotechnology made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1736 holding.
88 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.